Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Progress On Adding OTC Drugs To US Market? Room To Move But Label Format Limits Options

Jun 18 2021

• By Malcolm Spicer

Related Content

NSAIDs Marketed In US Will Have Stronger Label Warning About Risks During Late Pregnancy

Oct 15 2020

Before Asking FDA For Novel OTC Switch, Be Sure DFL Alone 'Can't Get There'

May 23 2019

US FDA: User-Error Risks Grow When OTC Brands Extend With Different Ingredients, Indications

Dec 09 2020

‘Heretical’ Rule Changes Could Make More Drugs Available OTC In US – Former NDAC Chair Brass

Jun 18 2021

US Consumers Don’t Know Where To Start With OTC Drug Fact Labels, Most Look Online For Help

Jun 15 2021

With Limits Of OTC Drug Fact Label ‘Simple Boxes,' Complicated Conditions Remain Rx-Only In US

Jun 14 2021

OTC DFL ‘Remains Static, Non-Customizable Tool’ As US FDA Lifts Curtain On Potential Changes

Jun 10 2021

Additional Topics

International United States FDA OTC Drugs Prescription To OTC Switch Advertising, Marketing & Sales Commercial Compliance Drug Approval Standards Enforcement Ingredients Manufacturing Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window